Caspases are crucial mediators of programmed cell death (apoptosis). Among them, caspase-3 is a frequently activated death protease, catalyzing the specific cleavage of many key cellular proteins. However, the specific requirements of this (or any other) caspase in apoptosis have remained largely unknown until now. Pathways to caspase-3 activation have been identified that are either dependent on or independent of mitochondrial cytochrome c release and caspase-9 function. Caspase-3 is essential for normal brain development and is important or essential in other apoptotic scenarios in a remarkable tissue-, cell type-or death stimulus-specific manner. Caspase-3 is also required for some typical hallmarks of apoptosis, and is indispensable for apoptotic chromatin condensation and DNA fragmentation in all cell types examined. Thus, caspase-3 is essential for certain processes associated with the dismantling of the cell and the formation of apoptotic bodies, but it may also function before or at the stage when commitment to loss of cell viability is made.
Introduction
Apoptosis is a fundamental and complex biological process that enables an organism to kill and remove unwanted cells during animal development, normal homeostasis and disease. 1, 2 Of all the proteins implicated in the activation and execution of apoptosis, the ICE-like proteases or caspases (14 so far identified in humans) stand out as being crucial for this process in diverse metazoan organisms. 3 ± 5 In mammals, caspases (principally caspase-3) appear to be activated in a protease cascade that leads to inappropriate activation or rapid disablement of key structural proteins and important signaling, homeostatic and repair enzymes. 3 Caspase-3 is a frequently activated death protease; however, the specific requirements of this (or any other) caspase in apoptosis were until now largely unknown. Recent work, reviewed here, has revealed that caspase-3 is important for cell death in a remarkable tissue-, cell type-or death stimulus-specific manner, and is essential for some of the characteristic changes in cell morphology and certain biochemical events associated with the execution and completion of apoptosis.
Caspase-3 is a frequently activated protease in mammalian cell apoptosis
It is clear that multiple pathways to apoptosis exist that originate from a variety of cell surface receptor-triggered or other events. 3, 6 Although there are at least 14 caspases in humans, 4, 7 only a subset of these enzymes is detectably proteolytically activated by various distinct death stimuli in different cell types. 8 ± 10 However, pro-caspase-3 is usually present and processed by autoproteolytic cleavage (or cleavage by one or more other proteases in trans) that leads to assembly of the active heterotetrameric enzyme. 8 ± 10 The frequent activation of caspase-3 in different cell types raises the fundamental question of whether this protease is required for the death of the cell and for the many morphological changes associated with apoptosis. Unfortunately, there is one other known caspase-3-like protease in vertebrates (caspase 7) with an analogous in vitro substrate preference to caspase-3 [DEVDG, where cleavage occurs between the aspartic acid (D) and the glycine (G)]. 3, 11 Moreover, the existence of other caspase-3-like proteases cannot be ruled out. Therefore, the activation of caspase-3 is not by itself proof that it is required for apoptotic events and cell death. neural apoptosis programme, or caspase-3 may lie at the heart of an essential neural death pathway.
Consistent with the lack of any obvious morphological defects in tissues or organs other than the brain, immature T and B cells from these mice undergo apoptosis normally. 12, 13 In contrast, caspase-3-defective peripheral T cells are less susceptible to CD3e-and Fas receptorinduced apoptosis and activation-induced cell death than similar cells from wild-type mice. 13 This indicates that caspase-3 contributes to apoptosis in peripheral T cells, but is dispensable during T and B cell differentiation. Remarkably, caspase-3-defective embryonic stem (ES) cells are highly resistant to apoptosis induced by UVirradiation and osmotic shock, but are as sensitive to girradiation and heat shocks as ES cells from wild-type mice. 13 In the absence of caspase-3, bone marrow neutrophils are slightly more resistant to cycloheximideinduced apoptosis; and caspase-3-defective mouse fibroblasts transformed with the adenovirus E1A gene and the activated p21 ras oncogene exhibit reduced and delayed cell death, which is completely restored by introducing the wildtype CASP-3 gene. 13 Thus, caspase-3 makes an essential contribution to cell death in some, but not all, scenarios in a remarkable tissue-, cell type-or death stimulus-specific manner. In contrast, all cell types examined from caspase-3-defective mice fail to display some typical hallmarks of apoptosis (extensive chromatin condensation and DNA fragmentation) following treatment with various death stimuli, whereas externalization of phosphatidylserine still occurs. 13 Similar results were independently obtained with the human MCF-7 breast carcinoma cell line in which the CASP-3 gene is functionally deleted due to a genomic mutation, introducing a premature stop codon in the mRNA. 14 It is known that MCF-7 cells are killed by various inducers of apoptosis in the complete absence of DNA strand breakage and without many of the characteristic morphological changes. 15 The absence of caspase-3 in this cell line explains why, since introduction of CASP-3 cDNA restores DNA fragmentation and membrane blebbing of MCF-7 cells undergoing apoptosis. 14 In a different approach, a selective inhibitor of caspase-3-like proteases was shown to block caspase-3 activation. DNA fragmentation and chromatin condensation in Jurkat T cells, and it was concluded that caspase-3 plays a central role in mediating nuclear apoptosis. 16 Together these results demonstrate that in multiple cell types, caspase-3 is required for some typical nuclear and other morphological changes associated with the completion of apoptosis and the formation of apoptotic bodies ( Figure 1 ). 13, 14, 16 These findings also show that loss of cell viability caused by various inducers of apoptosis can still occur without chromatin condensation, DNA fragmentation and membrane blebbing (Figure 1) .
What are the actual caspase-3-dependent steps that mediate the nuclear and other morphological changes of apoptosis? At least 42 of the 58 known caspase substrates are specifically cleaved by caspase-3 or a related protease, and caspase-3 can process pro-caspases 2, 6, 7 and 9, further illustrating the extensive involvement of caspase-3 or related proteases in cell death. 3, 4 TNF-or staurosporineinduced apoptosis of caspase-3-defective MCF-7 cells still results in the cleavage of several death substrates known to be susceptible to caspase-3, including poly(ADP-ribose) polymerase (PARP), the retinoblastoma protein and the DNA-dependent protein kinase catalytic subunit. 17 In contrast, the caspase-dependent cleavage of the actinbinding protein a-fodrin 18 into the typical 120-kDa fragment does not occur. Introduction of CASP-3 cDNA into MCF-7 cells restores a-fodrin cleavage as well as membrane blebbing. 14, 17 These results indicate that caspase-3 is essential for a-fodrin cleavage in MCF-7 cells, but dispensable for the cleavage of several other death substrates, and suggest that a-fodrin cleavage may contribute to blebbing ( Figure 1 ). Proteolysis of a-fodrin had earlier been suggested to contribute to the structural rearrangements including blebbing during apoptosis. 19 This is supported by the fact that fodrin (a major component of the cortical cytoskeleton of most eukaryotic cells) has binding sites for microtubules, calmodulin and actin. 17 However, since a-fodrin is also cleaved by calpain in a caspase-independent fashion, 18 further studies are needed to assess the specific function of the caspase-mediated cleavage of a-fodrin in the disassembly of the cell.
Evidence was presented that the caspase-3-mediated cleavages of PAK2 and gelsolin lead to the morphological changes associated with apoptosis. 20, 21 In the case of gelsolin, caspase-3 generates a fragment that severs actin filaments in an unregulated fashion. 20 The cleavage of gelsolin is an important event in apoptosis, because the enforced expression of the gelsolin fragment in several cells causes them to round up, detach and undergo nuclear fragmentation. In addition, TNF-and cycloheximide-treated neutrophils isolated from gelsolin-deficient mutant mice have an extremely delayed onset of membrane blebbing compared with wild-type neutrophils. 20 As caspase-3 is essential for gelsolin cleavage, 22 these results show that membrane blebbing is mediated, at least in part, by the activation of gelsolin by caspase-3.
ICAD/DFF-45 is a binding partner and inhibitor of the CAD endonuclease, and the specific cleavage of ICAD/ DFF-45 by caspase-3 relieves the inhibition and promotes the endonuclease activity of CAD, resulting in apoptotic DNA fragmentation. 23 ± 25 Caspase-3 is required for the carboxy-terminal cleavage of ICAD/DFF-45 that is necessary for the generation of the functional endonuclease. 22 Since DNA fragmentation is largely absent in apoptotic cells from mutant mice lacking ICAD/DFF-45 26 and is not detected in cells lacking caspase-3, 13,14 the cleavage of ICAD/DFF-45 resulting in the induction of the CAD endonuclease is a caspase-3-dependent step in a major pathway to DNA fragmentation in apoptosis.
These considerations raise a fundamental question. Is caspase-3 indispensable for cell death and/or morphological changes in certain cell types, or is it required only because other caspases are not expressed or activated, which could otherwise fulfill the function of caspase-3? We cannot, unfortunately, distinguish between these possibilities, because many investigators have only been able to detect the activation of a subset of caspases in various cell types, and rarely is the activation of all known caspases measured. 8 ± 10 In MCF-7 cells there is no detectable activation of caspase 7, which has an in vitro substrate specificity similar to that of caspase-3, leaving open the possibility that if it were activated, caspase 7 might be able to fulfill the function of caspase-3 in a-fodrin, gelsolin and ICAD/DFF-45 cleavage in these cells. 17 Similarly, it is worth considering that the remarkable celland tissue-selective requirement for caspase-3 in the CASP-3 7/7 mutant mice and cell lines may be explained, at least in part, by the absence of activated proteases that can substitute for caspase-3 in specific cell types (e.g. in the brain).
Signi®cance of cell death without morphological changes and DNA fragmentation
Surprisingly, mutant mice with a non-functional ICAD/DFF-45 gene are healthy with no obvious abnormalities. 26 In contrast to cells from wild-type mice, cells from these mutant animals exposed to apoptotic stimuli exhibit almost no DNA fragmentation, and chromatin condensation is severely impaired. These findings strongly imply that DNA degradation and perhaps also chromatin condensation are dispensable for in vivo programmed cell death during development of all tissues and organs, including the brain. 26 Figure 1 Involvement of caspase-3 in apoptosis pathways. The salient points are: (1) Pathways to caspase-3 activation may be dependent on 6, 29, 31, 32 or independent of 6,34 mitochondrial cytochrome c release (marked A, B). (2) Caspase-3 activation may be dependent on or independent of caspase-9 (marked A, B). 36, 37 (3) Cell death pathways exist that are either dependent on (marked A, B) or independent of caspase-3 (marked C). 12 ± 14,17,27,31 (4) Caspase-3 is required for a-fodrin, DFF-45 and gelsolin cleavage (MCF-7 cells), blebbing (MCF-7 cells), and chromatin condensation and DNA fragmentation (marked D). 13, 14, 17, 22, 23 (5) a-fodrin, DFF-45 and gelsolin cleavage by caspase-3, as well as chromatin condensation, DNA fragmentation and blebbing are not essential for loss of cell viability (marked E) 13 ± 15,17,22 As discussed above, distinct caspase-3-deficient cell types are efficiently killed by apoptosis inducers without blebbing, DNA fragmentation and proper chromatin condensation; 13 ± 15 yet other classic apoptotic events occur, including activation of caspases and specific cleavage of some death substrates. In other words, the death of cells from caspase-3-knockout mice and MCF-7 cell death appears to occur via an incomplete form of apoptosis. 13 ± 15 Cellular disintegration is unnecessary for the apoptotic death of cultured cell monolayers, because the dying cells simply detach from the plastic surface. In contrast, it has been assumed up till now that dying cells in the whole organism must shrink and be fragmented into discreet bodies that can be conveniently and rapidly engulfed by phagocytic cells. 2 Moreover, it has been pointed out that intact naked DNA is`dangerous stuff', as it could potentially colonize and scramble the genomes of neighboring cells. 25 The apparently normal programmed cell death during development in the ICAD/DFF-45deficient mice 26 and in the caspase-3-knockout mice in tissues and organs other than the brain 12, 13 is, therefore, puzzling as it implies that cell death and the removal of the corpse in vivo occurs without the need for many of the processes that up till now have been considered an integral part of apoptosis.
The cytochrome c ± caspase-3 connection
There is considerable evidence that disruption of mitochondrial functions (e.g. loss of transmembrane potential, permeability transition (PT) and release of cytochrome c leading to impaired electron transport) are important events in many apoptotic cell deaths (Figure 1 ). 27 ± 30 The release of cytochrome c induced by a variety of death stimuli results in the activation of a complex of apoptosis-activating factor 1 (Apaf-1) and caspase-9, leading to the cytochrome cdependent processing of pro-caspase-3 and apoptosis in a number of scenarios ( Figure 1) . 27,28,30 ± 32 Microinjected cytochrome c causes apoptosis of HeLa carcinoma and embryonic kidney 293 cells, but not of caspase-3-defective MCF-7 cells. 33 Transformation of MCF-7 cells with CASP-3 cDNA restores cytochrome c sensitivity, demonstrating that cytochrome c-mediated apoptosis requires caspase-3. 33 There is evidence that caspase-3 activation can also occur independently of mitochondrial cytochrome c release. 6, 34 For example, two cell type-dependent death pathways emanating from the Fas receptor have been discovered. 6 In type II cells, apoptotic cell death was inhibited by Bcl-2 and depended on the loss of mitochondrial functions; whereas in type I cells, apoptosis (involving caspase-3 activation) was not blocked by Bcl-2 even though Bcl-2 prevented disruption of mitochondrial functions including cytochrome c release. 6 In multiple myeloma cells, there exist cytochrome c-dependent and -independent mechanisms of apoptosis, both of which involve caspase-3 activation. 34 Once caspase-3 is activated, downstream death substrates are cleaved irrespective of the involvement of cytochrome c. 3, 4, 28 But caspase-3 might also amplify the upstream death cascade, including cytochrome c release from mitochondria, by cleaving Bcl-2, converting it from an anti-apoptotic to a pro-apoptotic protein. 35 Together these results indicate that mitochondria certainly play a role in apoptosis, but also mean that in some situations caspase-3 is activated when the mitochondrial step is completely bypassed. Furthermore, the release of cytochrome c can theoretically occur downstream of caspase-3 in some instances, and apoptotic cell death does not always involve the cytochrome c-dependent activation of caspase-3.
Embryos from caspase-9-knockout mice show evidence of impaired brain development associated with decreased apoptosis that is highly reminiscent of CASP-3 7/7 mutant mice. 36, 37 In the embryonic brains of CASP-9 7/7 mutant mice, the absence of caspase-9 prevents the activation of caspase-3; and the cytochrome c-dependent processing of pro-caspase-3 fails to occur in cytosolic extracts of caspase-9-deficient thymocytes and embryonic brain cells, but is restored after the addition of caspase-9. 37 Thus, caspase-9 is confirmed as a critical upstream activator of caspase-3 ( Figure 1 ). There appear to be at least two classes of caspase-9-dependent pathways, only one of which requires caspase-3. 36, 37 For example, caspase-9-dependent death of embryonic stem (ES) cells requires caspase-3 activation, whereas the caspase-9-dependent death of thymocytes induced by dexamethasone or g-radiation does not. The picture is even more complicated because caspase-9 is not always an obligatory upstream activator of caspase-3 ( Figure 1) . Thus, caspase-9 deficiency does not protect activated T cells from apoptosis induced by a-CD95 (via Fas) or a-CD3 and does not prevent caspase-3 activation in response to these stimuli in vivo. 36 This latter caspase-9independent pathway is reminiscent of the Fas-induced, Bcl-2-independent pathway to caspase-3 activation in type I cells mentioned above. 6 Curiously, the introduction of some pro-apoptotic proteins into cells causes death independently of caspases. Enforced expression of pro-apoptotic members of the Bcl-2 family (e.g. Bax) kills mammalian cells, accompanied by membrane alterations and DNA condensation, but without DNA fragmentation and caspase activation. 38 ± 40 These studies on the expression of Baxlike proteins are consistent with the conclusion that DNA fragmentation requires functional caspase-3 and, importantly, imply that not all morphological changes in dying cells require caspases. The fact that Bax can cause cytochrome c release 41 and promote mitochondrial PT or puncture the mitochondrion in a caspase-independent fashion 40 further emphasizes the importance of the disruption of mitochondrial functions in apoptosis.
Conclusions
Caspase-3 is probably the best understood of the mammalian caspases in terms of its specificity and roles in apoptosis (summarized in Figure 1 ). Overall, recent progress has generally confirmed the notion of multiple, complex death pathways (some of which require caspase-3 in specific cell types) that converge on common events including cell shrinkage, blebbing, chromatin condensation and DNA fragmentation (which appear to require caspase-3 in all cell types so far examined) ( Figure 1 ). The main message is that caspase-3 can exert multiple effects. Some of these effects are critical for cell death to occur, but only in specific cell types treated with some death inducers. Other effects of caspase-3 (certain morphological and nuclear changes resulting, at least in part, from the caspase-3-mediated cleavages of a-fodrin, gelsolin and ICAD/DFF-45) may ensure the efficient completion of the apoptotic process once the cell has been committed to die.
In the future, we must try to understand the molecular basis of the selective requirement for caspase-3 in neural development and in certain cell types induced to die with particular extracellular stimuli. 12, 13 In other words, exactly which caspase-3-dependent proteolytic events are required to cause these cells to die? Some of the answers will emerge with the discovery of new caspase-3 substrates; others will come from measuring the activation spectrum of known caspases in a range of caspase-3-deficient cells, and determining which (if any) of these caspases can substitute for caspase-3 (and which cannot). Another intriguing question is whether programmed cell death in the caspase-3-and ICAD/DFF-45-knockout mice really does occur without many of the morphological and nuclear changes that have been assumed to lead to the phagocytosis of apoptotic bodies.
